NCT00241657View on ClinicalTrials.gov

Immune Responses to BCG Vaccination in Malawi and the UK

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Immunity, CellularHypersensitivity, Delayed Type
Interventions
BIOLOGICAL

BCG

Trial Locations (2)

PO Box 36

Karonga Prevention Study, Chilumba

IG1 2QX

Redbridge and Waltham Forest Primary Care Trust, Ilford

All Listed Sponsors
lead

London School of Hygiene and Tropical Medicine

OTHER

NCT00241657 - Immune Responses to BCG Vaccination in Malawi and the UK | Biotech Hunter | Biotech Hunter